MACULAR DEGENERATION
Clinical trials for MACULAR DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new MACULAR DEGENERATION trials appear
Sign up with your email to follow new studies for MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Eye drops could replace needles for wet AMD?
Disease control CompletedThis study tested three different doses of SYL1801 eye drops in 99 people with wet age-related macular degeneration (AMD). The goal was to see if the drops are safe and can improve or maintain vision. Participants used the drops for a set period, and their vision was measured aft…
Matched conditions: MACULAR DEGENERATION
Phase: PHASE2 • Sponsor: Sylentis, S.A. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New combo therapy may cut need for frequent eye shots in macular degeneration
Disease control CompletedThis study tested whether adding a light-based treatment (photodynamic therapy) to the standard drug ranibizumab could reduce the number of eye injections needed for wet macular degeneration. Sixty adults over age 50 with the condition took part. The goal was to see if the combin…
Matched conditions: MACULAR DEGENERATION
Phase: PHASE2 • Sponsor: Texas Retina Associates • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New eye drug shows promise in slowing blindness from dry AMD
Disease control CompletedThis study tested an eye injection called Zimura (avacincaptad pegol) in 448 people with geographic atrophy, a late stage of dry age-related macular degeneration that causes permanent vision loss. The goal was to see if the drug could slow the growth of damaged areas in the retin…
Matched conditions: MACULAR DEGENERATION
Phase: PHASE3 • Sponsor: IVERIC bio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Can eye exercises help people with vision loss see better?
Knowledge-focused CompletedThis study looked at new ways to measure and train eye movements in 21 people with macular degeneration, a condition that causes central vision loss. The goal was to see if training could help them use their remaining side vision more effectively. The research focused on understa…
Matched conditions: MACULAR DEGENERATION
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC